{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:29:45Z","timestamp":1792794585813,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI097045"],"award-info":[{"award-number":["R01AI097045"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI45008"],"award-info":[{"award-number":["P30AI45008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Penn Centre for AIDS Research","id":[{"id":"https:\/\/ror.org\/047939x15","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1093\/infdis\/jiu040","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T21:13:20Z","timestamp":1389993200000},"page":"1754-1763","source":"Crossref","is-referenced-by-count":49,"title":["Clinical Outcomes Among Persons With Pulmonary Tuberculosis Caused by Mycobacterium tuberculosis Isolates With Phenotypic Heterogeneity in Results of Drug-Susceptibility Tests"],"prefix":"10.1093","volume":"209","author":[{"given":"Nicola M.","family":"Zetola","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases"},{"name":"Botswana\u2013University of Pennsylvania Partnership"},{"name":"Department of Medicine"},{"name":"Princess Marina Referral Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawangwa","family":"Modongo","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership"},{"name":"Princess Marina Referral Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Moonan","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ncube","sequence":"additional","affiliation":[{"name":"Botswana National Tuberculosis Programme, Gaborone, Botswana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keikantse","family":"Matlhagela","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Botswana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch","family":"Sepako","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Botswana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Collman","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Bisson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"},{"name":"Botswana\u2013University of Pennsylvania Partnership"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"key\n\t\t\t\t20180328165505_JIU040C1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00021-12","article-title":"Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control","volume":"25","author":"Cohen","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180328165505_JIU040C2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3201\/eid1907.130313","article-title":"Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection","volume":"19","author":"Hingley-Wilson","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C3","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"Van Deun","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/368368","article-title":"Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement","volume":"187","author":"Garcia de Viedma","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1086\/423144","article-title":"DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?","volume":"190","author":"Glynn","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.tube.2010.03.012","article-title":"The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture","volume":"90","author":"Martin","year":"2010","journal-title":"Tuberculosis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200503-449OC","article-title":"Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns","volume":"172","author":"van Rie","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328165505_JIU040C8","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/JCM.01377-13","article-title":"Diagnostic implications of inconsistent results obtained with the Xpert MTB\/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance","volume":"51","author":"Somoskovi","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1164\/ajrccm.169.2.952","article-title":"Statements of ATS, CDC, and IDSA on treatment of tuberculosis","volume":"169","author":"Caminero","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328165505_JIU040C10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(10)70139-0","article-title":"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"10","author":"Caminero","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/09031936.00073611","article-title":"WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update","volume":"38","author":"Falzon","year":"2011","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180328165505_JIU040C12","article-title":"Botswana National Tuberculosis Programme report","year":"2009"},{"key":"key\n\t\t\t\t20180328165505_JIU040C13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200210-1125OC","article-title":"Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days","volume":"167","author":"Jindani","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328165505_JIU040C14","article-title":"High prevelance of rifampin-monoresistant tuberculosis: a retrospective analysis among Iranian pulmonary tuberculosis patients","author":"Velayati","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328165505_JIU040C15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5588\/ijtld.12.0026","article-title":"Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana","volume":"16","author":"Zetola","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C16","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.5588\/ijtld.12.0403","article-title":"Prevalence of hypothyroidism among MDR-TB patients in Botswana","volume":"16","author":"Modongo","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C17","article-title":"BIAS 3 Report","author":"Ministry of Health of Botswana","year":"2008"},{"key":"key\n\t\t\t\t20180328165505_JIU040C18","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/JCM.42.5.2321-2325.2004","article-title":"Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria","volume":"42","author":"Cruciani","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C19","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/JCM.40.11.3976-3979.2002","article-title":"Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods","volume":"40","author":"Madison","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","article-title":"Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment","volume":"341","author":"van Rie","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328165505_JIU040C21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/JCM.01378-10","article-title":"Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa","volume":"49","author":"Cohen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C22","first-page":"99","article-title":"The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?","volume":"90","author":"Borgdorff","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180328165505_JIU040C23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(10)61972-1","article-title":"Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study","volume":"377","author":"Becerra","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328165505_JIU040C24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/ajrccm.163.3.2003070","article-title":"Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease","volume":"163","author":"Caminero","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328165505_JIU040C25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1098\/rsif.2006.0193","article-title":"Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission","volume":"4","author":"Cohen","year":"2007","journal-title":"J R Soc Interface"},{"key":"key\n\t\t\t\t20180328165505_JIU040C26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3201\/eid\/1706.101471","article-title":"Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru","volume":"17","author":"Cohen","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C27","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.00434-12","article-title":"Mixed tuberculosis infections in rural South Vietnam","volume":"50","author":"Huyen","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C28","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"Gagneux","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328165505_JIU040C29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"Gagneux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C30","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1086\/522987","article-title":"Evolution of the extensively drug-resistant F15\/LAM4\/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa","volume":"45","author":"Pillay","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C31","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/JCM.00556-10","article-title":"Microevolution of Mycobacterium tuberculosis in a tuberculosis patient","volume":"48","author":"Al-Hajoj","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C32","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/JCM.05203-11","article-title":"Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved","volume":"49","author":"Navarro","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C33","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/JCM.01285-11","article-title":"Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters","volume":"49","author":"Perez-Lago","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328165505_JIU040C34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5588\/ijtld.12.0314","article-title":"Anti-tuberculosis treatment outcomes in HIV-infected adults exposed to isoniazid preventive therapy in Botswana","volume":"17","author":"Sibanda","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328165505_JIU040C35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/209\/11\/1754\/16867256\/jiu040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T01:50:41Z","timestamp":1522288241000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/209\/11\/1754\/2908487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,1,16]]},"published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiu040","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}